#25USNASDAQMid-cap

NTNX

Nutanix

$74.14USD

Data as of 2026-10-14

Composite Score69.6Exceptional

≤−99

Margin of safety−136%Expensive

Fair value$31.43

Target$241.06

Loss chance69%Moderate-high

SizeLarge cap

SectorInformation Technology

DividendNone

TypeCommon stock

Price

Pillar breakdown

0–100 percentile rank against the current universe (sector-relative for Quality / Value / Growth / Profitability)

Information Technology median (n=191)

Quality
Profit margins & asset efficiency
93
Exceptional
Information Technology median (n=191) 49
Value
Price vs fundamentals
38
Weak
Information Technology median (n=191) 51
Growth
Revenue & earnings trajectory
80
Exceptional
Information Technology median (n=191) 51
Momentum
Recent price strength
78
Exceptional
Information Technology median (n=191) 54
Health
Balance sheet & solvency
59
Strong
Information Technology median (n=191) 65
Profitability
ROE, ROA, ROIC
76
Exceptional
Information Technology median (n=191) 50
Technical
Trend & volatility signals
68
Strong
Information Technology median (n=191) 56
Risk
Volatility & drawdown profile
43
Average
Information Technology median (n=191) 41

025405570100

Exceptional (70+)Strong (55–70)Average (40–55)Weak (25–40)Poor (<25)

Pillars not shown: Sentiment, ML (Phase 5+).

Risk Summary

3 active

Rank gates

Altman financial distress[altman_distress]Altman Z″ below 1.10 — financial-distress zone (Altman 1968).
Sloan accruals — top decile[sloan_accruals_top_decile]Within-sector top decile of accruals / assets (Sloan 1996).
Net share issuance — top decile[net_issuance_top_decile]Top-decile net issuance over the trailing year (Pontiff-Woodgate 2008 / Daniel-Titman 2006).

These flags keep the raw composite rank (project Rule 16) but forfeit the entered_top5 badge. Two of them — altman_distress and data_quality_input_corruption — additionally force a cautious recommendation; the others act as Top-5 disqualifiers without dictating the buy/hold/sell label on their own.

Manipulation index

Moderate

25/100

Composite penalty: −2.50 pts (informational; rank uses raw composite)

Also fired — not rank-gating (2)

Restatement history (10-K/A, 5y)[restatement_history]
Accruals momentum (Δ TATA > 0.05 over 3y)[accruals_momentum_high]

Rolls up Phase 4.5 earnings-manipulation defenses (Sloan · Beneish · Dechow · REM · restatement · late-filing · earnings- quality time-series) into a single 0-100 risk index. The soft composite penalty (max 10 pts) is informational only — the ranking uses the raw composite score per project Rule 16.

Fair price check

5 different valuation methods each estimate what NTNX should be worth, then we compare to today's price.

Heavily overvalued

Models suggest NTNX is far above estimated fair value

Today's price

$74.14

Median fair price

$31.43

-58% vs today's price

Of 4 methods:1 say cheap3 say pricey(1 outlier excluded)

P/E multiplesUndervalued
thinks it's a bargain — estimates $241.06, about 225% above today
EV/EBITDAOvervalued
thinks it's expensive — estimates $47.24, about 36% below today
DCF (2-stage)Overvalued
thinks it's expensive — estimates $31.43, about 58% below today
P/B multiplesOvervalued
thinks it's expensive — estimates $23.59, about 68% below today
Graham (defensive)Outlier
estimate looks unreliable — estimates $8.71 — likely unreliable

How to read this: “Cheap” = method's fair price is at least 20% above today. “Fair” = within ±10–20%. “Pricey” = at least 10% below today. Outliers (values more than 5× or less than 0.2× today's price) are excluded.

Fair price ensemble

Median fair: $31.43
Margin of safety(vs fair value): < −99%
Max (ex-outliers): $241.06
Tangible BVPS: $1.91

Extreme Graham estimate
Restatement history
Accruals momentum

Median of all applicable methods (current price $74.14). Per-method estimates + each method’s cheap/fair/pricey read are in the Fair price check above. Outliers above 5× or below 0.2× current price are excluded from the max but kept in the median. See methodology for the 6-method ensemble + 7 defenses.

Defense layer. Flags mark elevated risk, never confirmed fraud. This model cannot catch every manipulation and decays after publication — weigh it against its stated error rates.

Supporting dataRaw fundamentals & data-quality provenance behind the scores above

Raw fundamentals (SEC EDGAR)

Metric	Value
Market cap	$20.06B
Revenue (TTM)	$2.85B
Net income (TTM)	$1.51B
Operating cash flow (TTM)	$916.69M
CapEx (TTM)	$76.01M
Free cash flow (TTM)CFO − CapEx	$840.67M
Total assets	$5.07B
Total liabilities	$4.37B
Stockholders' equity	$702.57M
Cash & equivalents	$777.31M
Shares outstanding	270.57M
EPS (basic)	$5.59
EPS (diluted)	$5.59
P/E ratio (TTM)	13.27

TTM = trailing twelve months. Balance sheet items are point-in-time (latest filing).

Data quality

Latest filed date: 2026-09-18
Latest period end: 2026-08-31
Filing lag: 26 days
Missing metrics: 5(interest_expense, dividends_paid, inventory, long_term_debt, short_term_debt)